News and Press Releases
WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research
26 June 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, and the Multi-Regional Clinical Trials Center of Brigham...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 26, 2024
Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024
Thermo Fisher Scientific Expands Clinical Research Laboratory in Wisconsin
The PPD clinical research business' new laboratory will enhance services in new and emerging therapeutic areas, add 350 new jobs to region 18 June 2024 -- North Carolina, US --...
Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 19, 2024
Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting
PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award 17 June 2024 -- California, US -- The PPD clinical research business of Thermo Fisher Scientific,...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 17, 2024
Exonate appoints Dr Rafiq Hasan as Non-Executive Director
Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board 28 May 2024 -- Cambridgeshire, UK -- Exonate, a biotechnology company developing...
Category: Biotechnology, Pharmaceutical
Posted: May 28, 2024
Mission Therapeutics commences landmark trial of MTX325, a potential disease-modifying treatment for Parkinson’s Disease
Builds on preclinical proof-of-concept that MTX325 protects dopamine-producing brain cells by enhancing mitophagy – the process cells use to remove dysfunctional mitochondria 21 March 2024 -- Cambridge, UK -- Mission...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 21, 2024
Moneta (Building 280), Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research
Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...
Category: Clinical Trials
Posted: April 2, 2024
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET
One2Treat launches ground-breaking treatment-decision approach to clinical research and market access analysis
One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments 26 March 2024 -- Brussels, Belgium -- One2Treat, a...
Category: Clinical Trials, Pharmaceutical
Posted: March 26, 2024
HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215 for the treatment of acute and chronic liver diseases in Cell
Clinical and pre-clinical data generated from collaborations between the Tuebingen University Hospital, Germany, researchers from the Mayo Clinic in Rochester, USA and HepaRegeniX HRX-215 proved to be safe and well...
Category: Biotechnology
Posted: March 15, 2024
WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges
4 March 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the expansion of its capabilities with the...
Category: Clinical Trials
Posted: March 4, 2024
First MYC inhibitor to demonstrate safety and anti-tumour activity in a phase 1 first-in-human clinical trial
Developed in-house by VHIO-born spin-off company Peptomyc, OMO-103 is a mini-protein targeting the MYC oncogene which is found deregulated in most, if not all tumor types. Until recently, MYC has...
Category: Drug Discovery
Posted: February 7, 2024
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries
20 December 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimising pharmacovigilance...
Category: Clinical Trials
Posted: December 20, 2023
